These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38923205)

  • 1. C-reactive protein, inflammation and short-term mortality in acute heart failure.
    Cotter G; Pagnesi M; Davison B
    Eur J Heart Fail; 2024 Aug; 26(8):1759-1761. PubMed ID: 38923205
    [No Abstract]   [Full Text] [Related]  

  • 2. Pneumonia and inflammation in acute decompensated heart failure: a registry-based analysis of 1939 patients.
    Jobs A; Simon R; de Waha S; Rogacev K; Katalinic A; Babaev V; Thiele H
    Eur Heart J Acute Cardiovasc Care; 2018 Jun; 7(4):362-370. PubMed ID: 28357890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression and markers of inflammation as predictors of all-cause mortality in heart failure.
    Mommersteeg PMC; Schoemaker RG; Naudé PJW; Eisel ULM; Garrelds IM; Schalkwijk CG; Westerhuis BWJJM; Kop WJ; Denollet J
    Brain Behav Immun; 2016 Oct; 57():144-150. PubMed ID: 27013355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction.
    Abernethy A; Raza S; Sun JL; Anstrom KJ; Tracy R; Steiner J; VanBuren P; LeWinter MM
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29650706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein decrease associates with mortality reduction only in heart failure with preserved ejection fraction.
    Lourenço P; Pereira J; Ribeiro A; Ferreira-Coimbra J; Barroso I; Guimarães JT; Leite-Moreira A; Bettencourt P
    J Cardiovasc Med (Hagerstown); 2019 Jan; 20(1):23-29. PubMed ID: 30407267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between C-reactive protein levels at hospital admission and long-term mortality in patients with acute decompensated heart failure.
    Matsumoto H; Kasai T; Sato A; Ishiwata S; Yatsu S; Shitara J; Murata A; Kato T; Suda S; Matsue Y; Hiki M; Takagi A; Daida H
    Heart Vessels; 2019 Dec; 34(12):1961-1968. PubMed ID: 31104078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein: an inflammatory marker with prognostic value in patients with decompensated heart failure.
    Villacorta H; Masetto AC; Mesquita ET
    Arq Bras Cardiol; 2007 May; 88(5):585-9. PubMed ID: 17589635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein level on admission and time to and cause of death in patients hospitalized for acute heart failure.
    Minami Y; Kajimoto K; Sato N; Hagiwara N; Takano T;
    Eur Heart J Qual Care Clin Outcomes; 2017 Apr; 3(2):148-156. PubMed ID: 28927169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein in patients with acute heart failure and preserved ejection fraction.
    Villar S; Mollar A; Lorenzo M; Núñez G; de la Espriella R; Núñez J
    Rev Esp Cardiol (Engl Ed); 2024 May; 77(5):430-433. PubMed ID: 38000626
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased risk of cancer death in patients with chronic heart failure with a special reference to inflammation-A report from the CHART-2 Study.
    Oikawa T; Sakata Y; Nochioka K; Miura M; Abe R; Kasahara S; Sato M; Aoyanagi H; Shiroto T; Sugimura K; Takahashi J; Miyata S; Shimokawa H;
    Int J Cardiol; 2019 Sep; 290():106-112. PubMed ID: 31104823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and long-term mortality in acute congestive heart failure.
    Mueller C; Laule-Kilian K; Christ A; Brunner-La Rocca HP; Perruchoud AP
    Am Heart J; 2006 Apr; 151(4):845-50. PubMed ID: 16569545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental value of C-reactive protein to the MEESSI acute heart failure risk score.
    Wussler D; Belkin M; Shrestha S; Wernicke H; Papachristou A; Nowak A; Aliyeva F; Mork C; Strebel I; Huré GVF; Weil D; Michou E; Kozhuharov N; Gualandro DM; Puelacher C; Miró O; Rossello X; Martín-Sánchez FJ; Pocock SJ; Goudev A; Breidthardt T; Mueller C
    Eur J Heart Fail; 2024 Aug; 26(8):1749-1758. PubMed ID: 38923253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state.
    Förhécz Z; Gombos T; Borgulya G; Pozsonyi Z; Prohászka Z; Jánoskuti L
    Am Heart J; 2009 Oct; 158(4):659-66. PubMed ID: 19781428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.
    Demissei BG; Cotter G; Prescott MF; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Severin TM; Wang Y; Qian M; Teerlink JR; Metra M; Davison BA; Voors AA
    Eur J Heart Fail; 2017 Aug; 19(8):1001-1010. PubMed ID: 28133908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen-to-Albumin Ratio in Patients with Acute Heart Failure.
    Sawatani T; Shirakabe A; Shighihara S; Nishigoori S; Kiuchi K; Tani K; Kawakami S; Michiura Y; Kamitani S; Otsuka T; Kobayashi N; Asai K
    Int Heart J; 2024; 65(4):638-649. PubMed ID: 39085104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of biomarkers in heart failure: application of novel methods in the community.
    Dunlay SM; Gerber Y; Weston SA; Killian JM; Redfield MM; Roger VL
    Circ Heart Fail; 2009 Sep; 2(5):393-400. PubMed ID: 19808368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid composition in chronic heart failure: low circulating levels of eicosatetraenoic acid and high levels of vaccenic acid are associated with disease severity and mortality.
    Øie E; Ueland T; Dahl CP; Bohov P; Berge C; Yndestad A; Gullestad L; Aukrust P; Berge RK
    J Intern Med; 2011 Sep; 270(3):263-72. PubMed ID: 21466599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction.
    Tromp J; Khan MA; Klip IT; Meyer S; de Boer RA; Jaarsma T; Hillege H; van Veldhuisen DJ; van der Meer P; Voors AA
    J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28360225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
    Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
    Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of serum sialic acid and high-sensitivity C-reactive protein: markers of systemic inflammation in patients with chronic heart failure.
    Rajendiran KS; Ananthanarayanan RH; Satheesh S; Rajappa M
    Br J Biomed Sci; 2014; 71(1):29-32. PubMed ID: 24693572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.